Compare McKesson Corporation (MCK) vs Abrdn Physical Platinum Shares ETF (PPLT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Abrdn Physical Platinum Shares ETF — how do they compare? McKesson Corporation trades at $825.15 (market cap $97.35B), while Abrdn Physical Platinum Shares ETF trades at $14.82. The key difference: McKesson Corporation pays a 0.39% dividend while Abrdn Physical Platinum Shares ETF pays none, and McKesson Corporation is trading nearer its 52-week high, Abrdn Physical Platinum Shares ETF nearer its low. Which is the better fit depends on your goals.
| MCK | PPLT | |
|---|---|---|
Market Cap | $97.35B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $995.69 | $25.23 |
52-Week Low | $659.01 | $11.78 |
Enterprise Value | $101.98B | — |
Dividend Yield | 0.39% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $831.60, down 1.16% on the day, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with an 80% buy rating and a consensus price target of $932.83, implying potential upside. Revenue growth is robust, reaching $359.05 billion in 2025, though net margins remain thin at 1.18%. Cash flow from operations improved to $6.09 billion in 2025, supporting financial stability.
The outlook for MCK is positive, driven by earnings beats, analyst optimism, and solid cash generation. Key opportunities include growth in specialty pharma and oncology services. Risks involve policy uncertainties, competitive pressures, and execution challenges. The stock's current price near key support at $829 suggests a critical level for near-term direction.
PPLT, the abrdn Physical Platinum Shares ETF, trades at $14.47, down 0.21% on the day, amid a predominantly bearish technical signal with moving averages indicating strong selling pressure. The fund, which holds physical platinum, has seen significant volatility, with recent news highlighting its underperformance compared to gold and silver. A 10-for-1 stock split is scheduled for May 2026, which will adjust the share count without altering the fund's net asset value.
The outlook for PPLT is cautious, with technical indicators leaning bearish and sentiment mixed after a substantial rally. Investment opportunity hinges on a potential catch-up trade if platinum gains favor, but risks include commodity price swings and the ETF's lack of dividends, which may deter income-focused investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Abrdn Physical Platinum Shares ETF
PPLT is a physically-backed ETF designed to track the spot price of platinum, less the Trust's expenses. It holds physical platinum bullion in secure vaults, providing investors with a liquid and cost-effective way to access the platinum market without the logistical challenges of direct ownership.
Read more on PPLT →
